ArticleFrontiers in oncology2021

Crizotinib and Doxorubicin Cooperatively Reduces Drug Resistance by Mitigating MDR1 to Increase Hepatocellular Carcinoma Cells Death.

Ming Shao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.